Firefly Neuroscience, Inc. (NASDAQ:AIFF) Financings
Financings
| Raise | Date |
|---|---|
| Warrant exercise of common stock on exercise of warrants Closed: US$8.82M raised Use of proceeds: General working capital, including the initiative to build a foundation model of the human brain using its BNA technology platform | Feb 21, 2025 |
| Senior secured convertible notes Closed: US$2.4M raised Use of proceeds: Growth, commercialization of its FDA-510(k) cleared BNA technology, and general working capital | Dec 31, 2024 |
| Equity line of credit Announced: up to US$10M Use of proceeds: Growth, commercialization of its FDA-510(k) cleared BNA technology, and general working capital | Dec 31, 2024 |